Gonadotropin-independent precocious puberty

Gonadotropin-independent Precocious Puberty

Gonadotropin-independent precocious puberty, also known as peripheral precocious puberty, is a form of precocious puberty that occurs due to the early production of sex steroids from the gonads or adrenal glands, independent of the gonadotropins (luteinizing hormone and follicle-stimulating hormone) that typically regulate puberty. This condition leads to the development of secondary sexual characteristics at an unusually early age.

Pathophysiology

In gonadotropin-independent precocious puberty, the source of excess sex steroids is not the pituitary gland, which normally secretes gonadotropins to stimulate the gonads. Instead, the condition arises from:

• Autonomous production of sex steroids: This can occur due to tumors or hyperplasia of the adrenal glands or gonads, leading to increased levels of androgens or estrogens.
• Exogenous sources: Exposure to external sources of sex steroids, such as medications or environmental chemicals, can also cause this form of precocious puberty.
• Genetic conditions: Certain genetic disorders, such as McCune-Albright syndrome, can cause autonomous hormone production.

Clinical Presentation

Children with gonadotropin-independent precocious puberty may present with:

• Early development of secondary sexual characteristics, such as breast development in girls or testicular enlargement in boys.
• Accelerated growth and bone maturation, which can lead to early epiphyseal closure and short adult stature.
• Behavioral changes, such as increased aggression or mood swings.

Diagnosis

The diagnosis of gonadotropin-independent precocious puberty involves:

• Clinical evaluation: Assessment of physical signs of puberty and growth patterns.
• Hormonal assays: Measurement of sex steroid levels, which are elevated, and gonadotropin levels, which are low or normal.
• Imaging studies: Ultrasound or MRI may be used to identify tumors or hyperplasia in the adrenal glands or gonads.
• Genetic testing: In cases where a genetic syndrome is suspected.

Treatment

The treatment of gonadotropin-independent precocious puberty focuses on:

• Addressing the underlying cause: Surgical removal of tumors or treatment of hyperplasia.
• Medications: Use of drugs such as aromatase inhibitors or anti-androgens to block the effects of sex steroids.
• Monitoring growth and development: Regular follow-up to assess growth velocity and bone age.

Prognosis

The prognosis for children with gonadotropin-independent precocious puberty depends on the underlying cause and the effectiveness of treatment. Early intervention can help manage symptoms and improve outcomes.

Also see

• Precocious puberty
• Gonadotropin-dependent precocious puberty
• McCune-Albright syndrome
• Adrenal hyperplasia

Pediatric glossary of terms | Glossary of medical terms | Dictionary of pediatrics